121 related articles for article (PubMed ID: 2806005)
1. [Use of flow cytometry in the diagnosis of bladder tumor].
Ling CH
Zhonghua Wai Ke Za Zhi; 1989 May; 27(5):286-8, 317. PubMed ID: 2806005
[TBL] [Abstract][Full Text] [Related]
2. [Flow cytometry in diagnosis and treatment of bladder tumor].
Sun XJ; Song ZL; Wu DC
Zhonghua Wai Ke Za Zhi; 1994 Mar; 32(3):178-80. PubMed ID: 7842912
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of cytofluorometry in bladder tumors].
Verine JL; Coic H; Bertrand G; Lépinard V; Soret JY
Ann Urol (Paris); 1986; 20(3):175-85. PubMed ID: 3729300
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry of transitional cell carcinoma of the urinary bladder: influence of prior local therapy.
Têtu B; Katz RL; Kalter SP; Von Eschenbach AC; Barlogie B
Semin Diagn Pathol; 1987 Aug; 4(3):243-50. PubMed ID: 3671911
[TBL] [Abstract][Full Text] [Related]
5. [The diagnostic value of flow cytometric DNA analysis in bladder cancer--comparison with conventional cytology].
Kawasaki T
Hinyokika Kiyo; 1991 Nov; 37(11):1481-9. PubMed ID: 1767770
[TBL] [Abstract][Full Text] [Related]
6. [Flow cytofluorometric DNA analysis in fresh bladder specimens and its correlations between cytology and mitotic index].
Song LF
Zhonghua Wai Ke Za Zhi; 1990 May; 28(5):289-91, 318. PubMed ID: 2086099
[TBL] [Abstract][Full Text] [Related]
7. [Application of flow cytometry to the diagnosis of bladder carcinoma].
Matsuura T
Hinyokika Kiyo; 1986 Dec; 32(12):1917-24. PubMed ID: 2435136
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
[TBL] [Abstract][Full Text] [Related]
10. [Impulse cytophotometry and irrigation cytology in the diagnosis of bladder cancer].
Maier G; Blech M; Droese M; Ringert RH
Urologe A; 1990 Nov; 29(6):330-3. PubMed ID: 2291258
[TBL] [Abstract][Full Text] [Related]
11. DNA flow cytometry and bladder irrigation cytology in detection of bladder carcinoma.
Kumar NU; Dey P; Mondal AK; Singh SK; Vohra H
Diagn Cytopathol; 2001 Mar; 24(3):153-6. PubMed ID: 11241896
[TBL] [Abstract][Full Text] [Related]
12. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
[TBL] [Abstract][Full Text] [Related]
13. [Tumor markers and prognostic parameters in urinary bladder cancer].
Schneider AW; Huland H
Urologe A; 1990 Mar; 29(2):71-6. PubMed ID: 2184571
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometry versus urinary cytology in the diagnosis and follow-up of bladder tumors: critical review of a 5-year experience.
Billerey C; Lamy B; Bittard H; Rozan S; Carbillet JP
World J Urol; 1993; 11(3):156-60. PubMed ID: 8401634
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic methods in the diagnosis of invasive bladder cancer.
Krause FS; Feil G; Zumbrägel A; Bichler KH
Anticancer Res; 2000; 20(6D):5015-21. PubMed ID: 11326660
[TBL] [Abstract][Full Text] [Related]
16. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
17. Interphase cytogenetics as an adjunct in the cytodiagnosis of urinary bladder carcinoma. A comparative study of cytology, flow cytometry and interphase cytogenetics in bladder washes.
Cajulis RS; Haines GK; Frias-Hidvegi D; McVary K
Anal Quant Cytol Histol; 1994 Feb; 16(1):1-10. PubMed ID: 8011035
[TBL] [Abstract][Full Text] [Related]
18. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Lee DH; Yang SC; Hong SJ; Chung BH; Kim IY
Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens.
Cheng L; Reiter RE; Jin Y; Sharon H; Wieder J; Lane TF; Rao J
J Urol; 2003 Jun; 169(6):2094-100. PubMed ID: 12771726
[TBL] [Abstract][Full Text] [Related]
20. Detection of bladder carcinoma in females by flow cytometry and cytology.
Hermansen DK; Badalament RA; Fair WR; Kimmel M; Whitmore WF; Melamed MR
Cytometry; 1989 Nov; 10(6):739-42. PubMed ID: 2582965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
